SEC Form 4Coverage since May 28, 2026
$CLOV insider trading
Over the last 12 months, Clover Health Investments insiders reported no purchases and 16 sales totaling $3.5M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $3.5M 16 events
- Events · 12m
- 16 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $CLOV · 12Mvia TradingView
Top insiders · 12m
Reynoso Jamie L.CEO, Medicare Advantage7× · $203K
Soares KarenChief Legal Officer3× · $304K
Wai ConradCEO, Counterpart Health2× · $993K
Toy AndrewChief Executive Officer2× · $2.0M
THORNTON JOSEPH CLAYInterim CFO1× · $22K
All insider trades
16 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 51,700 | $4.51 | $233K | -3.3% | plan |
| Jul 17, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 4,839 | $4.53 | $22K | -0.2% | plan |
| Jul 15, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 10,519 | $4.67 | $49K | -0.7% | plan |
| Jul 15, 2026 | THORNTON JOSEPH CLAYInterim CFO · O | ▼ Sale | 4,630 | $4.67 | $22K | -0.4% | plan |
| Jul 15, 2026 | Toy AndrewChief Executive Officer · O·D | ▼ Sale | 62,711 | $4.67 | $293K | -0.7% | plan |
| Jul 15, 2026 | Wai ConradCEO, Counterpart Health · O | ▼ Sale | 24,215 | $4.67 | $113K | -2.1% | plan |
| Jul 15, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 13,119 | $4.67 | $61K | -0.5% | plan |
| Jul 8, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 2,384 | $4.68 | $11K | -0.1% | plan |
| Jul 6, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 6,229 | $5.26 | $33K | -0.2% | plan |
| Jul 1, 2026 | Toy AndrewChief Executive Officer · O·D | ▼ Sale | 313,476 | $5.32 | $1.7M | -3.2% | plan |
| Jun 17, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 2,360 | $4.78 | $11K | -0.1% | plan |
| Jun 16, 2026 | OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER · O | ▼ Sale | 12,102 | $4.86 | $59K | -3.9% | plan |
| Jun 15, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 4,681 | $4.61 | $22K | -0.3% | plan |
| Jun 15, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 6,350 | $4.61 | $29K | -0.2% | plan |
| Jun 11, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 7,289 | $4.91 | $36K | -0.3% | plan |
| May 28, 2026 | Wai ConradCEO, Counterpart Health · O | ▼ Sale | 220,426 | $3.99 | $879K | -13.7% | plan · indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CLOV feed.